AstraZeneca PLC (NASDAQ:AZN) is one of the most profitable blue chip stocks to invest in now. Guggenheim lifted the price ...

AstraZeneca PLC (NASDAQ:AZN) ranks among the 14 safe stocks to buy now for a starter stock portfolio. AstraZeneca PLC (NASDAQ ...

Astrazeneca (AZN) closed the most recent trading day at $189.90, moving -1.35% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.61%. Meanwhile, the ...

British drugmaker AstraZeneca Plc AZN has emerged as the leading contender to acquire French biotech Abivax SA ABVX, ...

AstraZeneca PLC (NYSE:AZN) is one of Goldman Sachs top healthcare stocks. On March 9, AstraZeneca PLC (NYSE:AZN) and Daiichi ...

Shares of AstraZeneca (NASDAQ: AZN) have jumped more than 10% this week. On Monday, the British drugmaker reported positive results from a clinical study of Enhertu in treating HER2-positive early ...

AstraZeneca AZN stock has risen 15% so far this year compared with an increase of 0.2% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

AstraZeneca ( (GB:AZN)) just unveiled an update. AstraZeneca has published its 2025 Annual Report and Form 20-F Information, making the document available via the U.K. National Storage Mechanism and ...

French biotech Abivax has been the subject of intense takeover speculation for months. But a spokesperson denied a report by La Lettre that AstraZeneca was ...